http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103251715-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae15396132411fbb4b24a51c72d80846 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
filingDate | 2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0851c3792b5b0554e71724d230c1f91c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_229991d580b38382439d5856d4083b17 |
publicationDate | 2014-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103251715-B |
titleOfInvention | Composition for regulating Th1/Th2 cell ratio and preparation method thereof |
abstract | The invention relates to a composition for regulating a Th1/Th2 cell ratio. The active ingredients of the composition are prepared by the following raw materials in parts by weight: 40-80 parts of cordyceps militaris, 300-700 parts of radix pseudostellariae, 100-300 parts of citron, 100-300 parts of fructus citri sarcodactylis and 1-5 parts of ginkgo biloba extract; and the active ingredients are extracted and prepared to form granules, powder, tablets or capsules through utilizing a convention technology. The invention further discloses an application of the composition in preparing health-care food for increasing Th1 cells, reducing Th2 cells and regulating the Th1/Th2 cell ratio. |
priorityDate | 2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.